DK0504177T3 - IL-11, et pattedyrcytokin - Google Patents

IL-11, et pattedyrcytokin

Info

Publication number
DK0504177T3
DK0504177T3 DK90917548T DK90917548T DK0504177T3 DK 0504177 T3 DK0504177 T3 DK 0504177T3 DK 90917548 T DK90917548 T DK 90917548T DK 90917548 T DK90917548 T DK 90917548T DK 0504177 T3 DK0504177 T3 DK 0504177T3
Authority
DK
Denmark
Prior art keywords
mammalian cytokine
cells involved
cytokine
stimulating
processes
Prior art date
Application number
DK90917548T
Other languages
Danish (da)
English (en)
Inventor
Yu-Chung Yang
Frances K Bennett
R Paul Stephen
Original Assignee
Childrens Medical Center
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center, Genetics Inst filed Critical Childrens Medical Center
Application granted granted Critical
Publication of DK0504177T3 publication Critical patent/DK0504177T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2073—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5431—IL-11
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90917548T 1989-11-22 1990-11-20 IL-11, et pattedyrcytokin DK0504177T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44110089A 1989-11-22 1989-11-22
US07/526,474 US5215895A (en) 1989-11-22 1990-05-21 Dna encoding a mammalian cytokine, interleukin-11
PCT/US1990/006803 WO1991007495A1 (en) 1989-11-22 1990-11-20 A mammalian cytokine, il-11

Publications (1)

Publication Number Publication Date
DK0504177T3 true DK0504177T3 (da) 2001-04-02

Family

ID=27032674

Family Applications (2)

Application Number Title Priority Date Filing Date
DK90917548T DK0504177T3 (da) 1989-11-22 1990-11-20 IL-11, et pattedyrcytokin
DK066692A DK66692A (da) 1989-11-22 1992-05-21 En mammal cytokin, il-11

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK066692A DK66692A (da) 1989-11-22 1992-05-21 En mammal cytokin, il-11

Country Status (13)

Country Link
US (4) US5215895A (de)
EP (1) EP0504177B1 (de)
JP (2) JP2688539B2 (de)
KR (1) KR970005050B1 (de)
AT (1) ATE199096T1 (de)
CA (1) CA2069428C (de)
DE (1) DE69033700T2 (de)
DK (2) DK0504177T3 (de)
ES (1) ES2156852T3 (de)
GR (1) GR3035627T3 (de)
HU (1) HU215233B (de)
MX (1) MX9203439A (de)
WO (1) WO1991007495A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215895A (en) * 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
WO1992004455A1 (en) * 1990-08-29 1992-03-19 Genetics Institute, Inc. Multidomain hematopoiesis stimulators
JP2752819B2 (ja) * 1990-11-08 1998-05-18 三共株式会社 新規サイトカイン
ATE238417T1 (de) 1991-11-04 2003-05-15 Inst Genetics Llc Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
US5460810A (en) * 1992-09-02 1995-10-24 Genetics Institute, Inc. Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
US5602301A (en) * 1993-11-16 1997-02-11 Indiana University Foundation Non-human mammal having a graft and methods of delivering protein to myocardial tissue
EP0675201A1 (de) * 1994-03-31 1995-10-04 Amgen Inc. Zusammensetzungen und Verfahren zur Anregung des Wachstums und der Differenzierung von Megakaryozyten
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
US6270757B1 (en) * 1994-04-21 2001-08-07 Genetics Institute, Inc. Formulations for IL-11
US5582821A (en) * 1994-07-22 1996-12-10 Genetics Institute, Inc. Methods for treating bleeding disorders
US6274547B1 (en) * 1996-06-14 2001-08-14 Genetics Institute, Inc. Methods comprising the use of human interleukin-11 receptor proteins
EP0797664B1 (de) 1994-12-22 2006-10-18 Genetics Institute, LLC Verwendung eines menschlichen interleukin-11 rezeptors
US5760189A (en) * 1995-06-02 1998-06-02 Genetics Institute, Inc. Protein recovery & purification methods
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
WO1996041607A2 (en) * 1995-06-09 1996-12-27 Yeda Research And Development Co. Ltd. Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11
US6126933A (en) * 1995-06-27 2000-10-03 Genetics Institute Methods of treating inflammatory bowel diseases by administering IL-11
US6887461B1 (en) * 1998-10-26 2005-05-03 Genetics Institute, Llc Method of using IL-11 for treating mucositis
US6540993B1 (en) 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US5679339A (en) * 1995-06-27 1997-10-21 Keith; James Method of using IL-11 for treating spondyloarthropies
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
EP0871472A4 (de) * 1995-10-27 2001-05-30 Amrad Operations Pty Ltd Cytokine und ihre verwendung in behandlung und/oder vorbeugung von brustkrebs
KR100426286B1 (ko) * 1996-01-09 2004-06-30 주식회사 엘지생명과학 효모를이용한인간인터루킨-11의제조방법
AUPO439396A0 (en) 1996-12-24 1997-01-23 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
DE69916022T2 (de) * 1998-01-23 2004-09-02 Genetics Institute, LLC, Cambridge Methode zur Verwendung von IL-11 zur Verstärkung der zellvermittelten Immunität zur Behandlung verschiedener viraler und parasitärer Infektionen und Krebs
CA2237915A1 (en) 1998-05-19 1999-11-19 Stephen Shaughnessy Osteoporosis treatment
US6265165B1 (en) * 1998-11-12 2001-07-24 The Regents Of The University Of California Methods for EST-specific full length cDNA cloning
US6953777B2 (en) * 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
AU3738300A (en) * 1999-03-11 2000-09-28 Genetics Institute Inc. Use of interleukin-11 to prevent immune-mediated cytotoxicity
EP1096948A4 (de) * 1999-04-15 2004-04-07 Inst Genetics Llc Verwendung von interleukin-11 zur behandlung gastrointestinaler krankheiten
US6274135B1 (en) * 1999-06-22 2001-08-14 Genetics Institute, Inc. Method of using IL-11 for inflammation associated with acute pancreatitis
EP1368486A4 (de) * 1999-07-15 2009-04-01 Genetics Inst Llc Formulierungen für il-11
AU2002362088A1 (en) * 2001-12-06 2003-06-23 Catholic University Method and composition for inducing weight loss
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
CN1688293A (zh) * 2002-09-16 2005-10-26 韦思公司 多肽治疗剂口服给药的缓释配方及其使用方法
CN1878565B (zh) 2003-09-12 2011-01-12 惠氏公司 用于递送成骨蛋白的注射型磷酸钙固体小棒剂和糊剂
WO2005085283A1 (ja) * 2004-03-03 2005-09-15 Yamanouchi Pharmaceutical Co., Ltd. 修飾インターロイキン−１１及びそれを含有する医薬組成物
WO2006081379A1 (en) * 2005-01-26 2006-08-03 Wyeth Use of sfrps as markers of bmp activity
BRPI0619476A2 (pt) * 2005-12-05 2011-10-04 Wyeth Corp composições de interleucina-11 e métodos de uso
US20080069796A1 (en) * 2006-07-31 2008-03-20 Kim Jong-Mook Low Dose Treatment with an Interleukin-11 Analog
WO2011151716A1 (en) 2010-06-04 2011-12-08 Lupin Limited Process for the purification of recombinant human il-11
EP2625577B1 (de) 2010-10-08 2019-06-26 Terumo BCT, Inc. Anpassbares verfahren und systeme für züchtung und ernte von zellen in einem hohlfaser-bioreaktorsystem
US9320777B2 (en) 2011-05-13 2016-04-26 Bolder Biotechnology, Inc. Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure
US10633625B2 (en) 2013-11-16 2020-04-28 Terumo Bct, Inc. Expanding cells in a bioreactor
EP3122866B1 (de) 2014-03-25 2019-11-20 Terumo BCT, Inc. Passives ersetzen von medien
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11229683B2 (en) 2015-09-18 2022-01-25 Bolder Biotechnology, Inc. Hematopoietic growth factor proteins and analogs thereof and angiotensin converting enzyme inhibitors for treatment of radiation exposure
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
JP7227159B2 (ja) * 2017-01-16 2023-02-21 ナンシャ・バイオロジックス・（ホンコン）・リミテッド 酵母における組換えｉｌ－１１の生産のためのシステムおよび方法
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3601521A2 (de) 2017-03-31 2020-02-05 Terumo BCT, Inc. Zellexpansion
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863727A (en) * 1986-04-09 1989-09-05 Cetus Corporation Combination therapy using interleukin-2 and tumor necrosis factor
US5215895A (en) * 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
US5371193A (en) * 1990-05-21 1994-12-06 Genetics Institute, Inc. - Legal Affairs Mammalian cytokine, IL-11
JPH0571866A (ja) * 1991-09-17 1993-03-23 Matsushita Refrig Co Ltd 断熱箱体

Also Published As

Publication number Publication date
US6066317A (en) 2000-05-23
EP0504177A1 (de) 1992-09-23
DK66692D0 (da) 1992-05-21
DE69033700D1 (de) 2001-03-15
US5700664A (en) 1997-12-23
AU644389B2 (en) 1993-12-09
HU9201712D0 (en) 1992-09-28
ES2156852T3 (es) 2001-08-01
CA2069428A1 (en) 1991-05-23
US5854028A (en) 1998-12-29
US5215895A (en) 1993-06-01
JP2688539B2 (ja) 1997-12-10
HUT64595A (en) 1994-01-28
WO1991007495A1 (en) 1991-05-30
CA2069428C (en) 2001-07-31
JP2783361B2 (ja) 1998-08-06
KR970005050B1 (ko) 1997-04-11
EP0504177B1 (de) 2001-02-07
MX9203439A (es) 1992-08-01
HU215233B (hu) 1998-11-30
JPH05504560A (ja) 1993-07-15
KR920703819A (ko) 1992-12-18
DE69033700T2 (de) 2001-09-13
AU6757890A (en) 1991-06-13
JPH104982A (ja) 1998-01-13
DK66692A (da) 1992-07-22
GR3035627T3 (en) 2001-06-29
ATE199096T1 (de) 2001-02-15

Similar Documents

Publication Publication Date Title
DK0504177T3 (da) IL-11, et pattedyrcytokin
DE3884607D1 (de) Ausgangsrechnungsabwicklungssystem und -verfahren.
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
ES8606289A1 (es) Un procedimiento para la preparacion de piridazinaminas.
ES2056817T5 (es) Transformacion de trichoderma.
MY102472A (en) Preparation of funtional human urokinase proteins.
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
NZ223551A (en) Human interleukin-3 and related proteins, production of these using genetic engineering methods and pharmaceutical compositions
ES8403157A1 (es) Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral.
EP0306219A3 (de) HIV-Proteine und Peptide zur Verwendung in Diagnose, Prophylaxe und Therapie von AIDS
DE3061854D1 (en) Process for the preparation of interferon and culture medium composition used in it
NO922456L (no) Bcrf1-proteiner som inhibitorer av interferon-gamma
DE3585049D1 (de) Monoklonale antikoerper.
DK415388D0 (da) Farmaceutiske praeparater indeholdende pyrimidinderivater og fremgangsmaade til fremstilling deraf
ATE84221T1 (de) Arzneimittel mit methylcellulose.
FI880636A0 (fi) Foerfarande foer inaktivering av med hoelje foersedda virus i en medelst en cell in vitro framstaellda proteinprodukter.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
FI960839A0 (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
DE3675631D1 (de) In-vitro-kulturverfahren.
ATE100312T1 (de) Einkristalle von -g(b)-phenylpropiophenonen.
IT1053845B (it) Procedimento per l arricchimento di prodotti agricoli in proteine e vitamine
ES8300475A1 (es) Un procedimiento para la preparacion de un alergeno
IT8123860A0 (it) 4-carbamoilossi-ossazafosforine metodo per produrle e preparazioni farmaceutiche che le contengono.
DK222988A (da) Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer